118 related articles for article (PubMed ID: 7595400)
21. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
22. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
Salsman J; Wang X; Frappier L
Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
[TBL] [Abstract][Full Text] [Related]
23. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
[TBL] [Abstract][Full Text] [Related]
24. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0.
Maul GG; Everett RD
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1223-33. PubMed ID: 8207389
[TBL] [Abstract][Full Text] [Related]
25. The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau C; Marchio A; Fagioli M; Jansen J; Falini B; Lebon P; Grosveld F; Pandolfi PP; Pelicci PG; Dejean A
Oncogene; 1995 Sep; 11(5):871-6. PubMed ID: 7545807
[TBL] [Abstract][Full Text] [Related]
26. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
27. Cross-reactivity of the anti-PML antibody PG-M3 with the herpes simplex virus type 1 immediate early protein ICP4.
Boulware SL; Weber PC
J Gen Virol; 2000 Jul; 81(Pt 7):1773-7. PubMed ID: 10859383
[TBL] [Abstract][Full Text] [Related]
28. Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.
Paulus C; Harwardt T; Walter B; Marxreiter A; Zenger M; Reuschel E; Nevels MM
PLoS Pathog; 2020 May; 16(5):e1008537. PubMed ID: 32365141
[TBL] [Abstract][Full Text] [Related]
29. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
Carlile GW; Tatton WG; Borden KL
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
[TBL] [Abstract][Full Text] [Related]
30. N-terminal determinants of human cytomegalovirus IE1 protein in nuclear targeting and disrupting PML-associated subnuclear structures.
Lee HR; Huh YH; Kim YE; Lee K; Kim S; Ahn JH
Biochem Biophys Res Commun; 2007 May; 356(2):499-504. PubMed ID: 17367754
[TBL] [Abstract][Full Text] [Related]
31. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection.
Tavalai N; Papior P; Rechter S; Stamminger T
J Virol; 2008 Jan; 82(1):126-37. PubMed ID: 17942542
[TBL] [Abstract][Full Text] [Related]
32. Activity and intracellular localization of the human cytomegalovirus protein pp71.
Marshall KR; Rowley KV; Rinaldi A; Nicholson IP; Ishov AM; Maul GG; Preston CM
J Gen Virol; 2002 Jul; 83(Pt 7):1601-1612. PubMed ID: 12075078
[TBL] [Abstract][Full Text] [Related]
33. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
34. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection.
Puvion-Dutilleul F; Venturini L; Guillemin MC; de Thé H; Puvion E
Exp Cell Res; 1995 Dec; 221(2):448-61. PubMed ID: 7493645
[TBL] [Abstract][Full Text] [Related]
35. Nuclear IE2 structures are related to viral DNA replication sites during baculovirus infection.
Mainz D; Quadt I; Knebel-Mörsdorf D
J Virol; 2002 May; 76(10):5198-207. PubMed ID: 11967334
[TBL] [Abstract][Full Text] [Related]
36. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components.
Grande MA; van der Kraan I; van Steensel B; Schul W; de Thé H; van der Voort HT; de Jong L; van Driel R
J Cell Biochem; 1996 Dec; 63(3):280-91. PubMed ID: 8913879
[TBL] [Abstract][Full Text] [Related]
37. Altered distribution of the promyelocytic leukemia-associated protein is associated with cellular senescence.
Jiang WQ; Ringertz N
Cell Growth Differ; 1997 May; 8(5):513-22. PubMed ID: 9213441
[TBL] [Abstract][Full Text] [Related]
38. A role for cytoplasmic PML in cellular resistance to viral infection.
McNally BA; Trgovcich J; Maul GG; Liu Y; Zheng P
PLoS One; 2008 May; 3(5):e2277. PubMed ID: 18509536
[TBL] [Abstract][Full Text] [Related]
39. Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells.
Björndal AS; Szekely L; Elgh F
BMC Microbiol; 2003 Apr; 3():6. PubMed ID: 12697055
[TBL] [Abstract][Full Text] [Related]
40. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
